Nerve block for diabetic nerve pain in the leg
Part of Hormones & metabolism clinical trials.
This trial tests a numbing medicine injected near a major leg nerve (femoral nerve) to see if it can reduce pain and improve function for people with diabetic peripheral neuropathy (nerve damage from diabetes).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have type 2 diabetes (diagnosed with standard criteria).
- You must have nerve damage in your legs from diabetes (diabetic peripheral neuropathy).
- You cannot have nerve damage from other causes (like certain medications, alcohol, or autoimmune disease).
- You cannot have a diabetic foot ulcer, gangrene, or a known injury or surgery to your leg bones or joints.
- You must not have a history of allergy to numbing medicines, bleeding problems, or infection near the injection site.
- You must not be currently on strong opioid pain medicines (like morphine or oxycodone).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses ultrasound to examine nerves in people with type 2 diabetes who have nerve damage in their legs or feet. Researchers will compare ultrasound findings with blood tests to understand why some people develop this complication and how to better detect it early.
This trial studies whether a numbing “nerve block” can reduce long-lasting nerve pain caused by diabetic neuropathy. You may keep your usual pain medicines, and the study will mainly check whether you fit the safety and diagnosis criteria.
This study looks at how well a numbing shot around the ankle (called an ankle block) works for pain after leg surgery. It compares people with and without diabetes to see if there are any differences in pain relief.
This study analyzes blood samples from people with diabetes to understand what causes nerve pain and damage in the legs and feet. Researchers will compare blood from three groups: people with diabetic nerve pain, people with diabetes but no nerve problems, and healthy volunteers without diabetes.
This trial tests a minimally invasive ultrasound-guided procedure that uses fluid injection to free trapped nerves in the lower legs of people with diabetes. The goal is to relieve pain, numbness, and weakness when standard medications haven't worked well enough.
This study uses ultrasound (an imaging test) to measure the nerves in the legs of people with type 2 diabetes who have nerve damage. It helps doctors learn more about how diabetes affects nerves.
Hear when a new Diabetes Mellitus, Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.